1. Home
  2. IIIN vs PRME Comparison

IIIN vs PRME Comparison

Compare IIIN & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IIIN

Insteel Industries Inc.

HOLD

Current Price

$31.58

Market Cap

639.8M

Sector

Industrials

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.42

Market Cap

666.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IIIN
PRME
Founded
1953
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
639.8M
666.1M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
IIIN
PRME
Price
$31.58
$3.42
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$6.42
AVG Volume (30 Days)
135.4K
3.8M
Earning Date
01-15-2026
11-07-2025
Dividend Yield
3.54%
N/A
EPS Growth
112.14
N/A
EPS
2.10
N/A
Revenue
$647,706,000.00
$5,977,000.00
Revenue This Year
$14.97
$111.80
Revenue Next Year
$7.00
N/A
P/E Ratio
$15.08
N/A
Revenue Growth
22.39
647.13
52 Week Low
$22.49
$1.11
52 Week High
$41.64
$6.94

Technical Indicators

Market Signals
Indicator
IIIN
PRME
Relative Strength Index (RSI) 44.45 39.71
Support Level $31.93 $3.33
Resistance Level $32.64 $4.12
Average True Range (ATR) 0.80 0.24
MACD -0.05 -0.03
Stochastic Oscillator 18.40 13.08

Price Performance

Historical Comparison
IIIN
PRME

About IIIN Insteel Industries Inc.

Insteel Industries Inc produces and sells prestressed concrete strand (PC strand) and welded wire reinforcement (WWR). PC strand, a high-strength seven-wire cable, is used to strengthen precast concrete in structures like bridges, parking decks, and buildings, enabling longer spans and slimmer designs. WWR includes engineered structural mesh for primary reinforcement, concrete pipe reinforcement for drainage and sewage systems, and standard WWR for crack control in residential and light commercial construction. The company serves markets in the United States and internationally, with the majority of revenue generated in the United States.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: